Infinitus Systems is a healthcare-focused AI company specializing in automated agents for complex clinical and administrative workflows, and this weekly summary reviews its latest product and go-to-market activities. The company is emphasizing AI-driven support for the full patient journey, particularly in specialty pharmacy and chronic care management.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
During the week, Infinitus Systems unveiled Infinitus Studio, a no-code AI agent builder designed to let health systems and payers design, test, and deploy AI agents in plain language. The platform integrates with existing operational systems and is marketed with claims of up to 90% faster deployment and 40% higher accuracy, with an emphasis on safety and compliance.
Infinitus Studio is being introduced through an early-access program rather than broad general availability, signaling a controlled rollout focused on validation and feedback. This measured approach is aimed at securing reference customers, refining features, and building a base of recurring revenue if users achieve meaningful workflow efficiency gains.
The company also reiterated its strategic focus on AI agents for chronic care management, positioning automation as a way to extend care team capacity without proportional staffing growth. This alignment with value-based care and workflow automation priorities could make Infinitus’ platform attractive to both providers and payers managing long-term conditions.
Infinitus Systems highlighted its ongoing relationship with Dr. Zeke Emanuel, underscoring collaboration on health policy, AI ethics, and innovation. This association may enhance the company’s credibility with large health systems and insurers that closely scrutinize clinical, regulatory, and ethical frameworks when evaluating AI vendors.
On the commercial front, Infinitus Systems is actively participating in Asembia’s AXS26 Summit in Las Vegas, treating the event as a key venue for business development in specialty pharmacy and pharma services. CEO and co-founder Ankit Jain is scheduled to appear on stage with Optum Rx CIO Santiago Abraham, and the company is using booth 1538 to showcase how its AI offerings support the complete patient journey.
Visibility at AXS26 places Infinitus Systems alongside major pharmacy benefit and healthcare technology stakeholders, potentially enhancing its partnership and customer pipeline prospects. While no commercial outcomes were disclosed, the blend of product launches, strategic focus areas, expert partnerships, and high-profile conference presence marks a week of notable strategic progress for the company.

